Chemoradiotherapy for Solitary Skeletal Muscle Metastasis from Oesophageal Cancer: Case Report and Brief Literature Review

Anticancer Res. 2017 Oct;37(10):5687-5691. doi: 10.21873/anticanres.12005.

Abstract

Background: The incidence of skeletal muscle metastasis from oesophageal cancer is very low, and the treatment strategy has not been established.

Case report: A 77-year-old man underwent oesophagectomy following neoadjuvant chemotherapy for oesophageal squamous cell carcinoma (CT-pT3 N0 M0, CT-pStage II). Fourteen months after surgery, he became aware of a subcutaneous tumour in his left forearm. Computed tomography and fluorodeoxyglucose positron-emission tomography revealed a 65×75 mm intramuscular nodular lesion with a standardized uptake value of 8.5. Further examination by biopsy strongly suggested this was a solitary metastasis from oesophageal cancer. The patient received chemoradiotherapy with two cycles of 5-fluorouracil combined with cisplatin and radiation. Clinical complete response was confirmed by imaging 7 months after chemoradiation and no recurrence has occurred at 20 months since chemoradiation.

Conclusion: Radiotherapy or chemoradiotherapy can be an alternative locoregional therapy to surgery for solitary skeletal muscle metastasis.

Keywords: Oesophageal cancer; case report; chemoradiotherapy; skeletal muscle metastasis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Biopsy
  • Carcinoma, Squamous Cell
  • Chemoradiotherapy*
  • Cisplatin / administration & dosage
  • Esophageal Neoplasms / pathology*
  • Esophageal Squamous Cell Carcinoma
  • Fluorouracil / administration & dosage
  • Forearm
  • Humans
  • Immunohistochemistry
  • Magnetic Resonance Imaging
  • Male
  • Muscle Neoplasms / chemistry
  • Muscle Neoplasms / secondary*
  • Muscle Neoplasms / therapy*
  • Muscle, Skeletal / chemistry
  • Muscle, Skeletal / pathology*
  • Neoplasm Staging
  • Neoplasms, Squamous Cell / chemistry
  • Neoplasms, Squamous Cell / secondary*
  • Neoplasms, Squamous Cell / therapy*
  • Positron-Emission Tomography
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Cisplatin
  • Fluorouracil